Biodextris
Entry
2024
Hold
<1yr
Exit
2024
Who owns Biodextris?
Biodextris is a Canadian Biotech company, formerly owned by ARCHIMED, exited in 2024 (exit via Continuation Vehicle). No current private equity owner is on file.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Exit Type
Continuation Vehicle
Buyer
MED Bio
Exit Year
2024
More from MED Rise
Other portfolio companies in the same fund.
Spain
United States
France
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Biodextris?
Biodextris was formerly owned by ARCHIMED, exited in 2024. No current private equity owner is on file.
Who did Biodextris sell to?
ARCHIMED sold Biodextris to MED Bio in 2024 (Continuation Vehicle).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue